Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor marker CA 15-3 in breast cancer patients.
Fejzić H, Mujagić S, Azabagić S, Burina M. Fejzić H, et al. Acta Med Acad. 2015;44(1):39-46. doi: 10.5644/ama2006-124.125. Acta Med Acad. 2015. PMID: 26062696 Free article.
Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].
Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP. Kahlon G, et al. Among authors: fejzic h. Bioorg Med Chem Lett. 2021 Apr 1;37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13. Bioorg Med Chem Lett. 2021. PMID: 33588181 Free article. No abstract available.
Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin.
Kahlon G, Lira R, Masvlov N, Pompa E, Brar N, Eagon S, Anderson MO, Andaya A, Chance JP, Fejzic H, Keniston A, Huynh N, Celis N, Vidal B, Trieu N, Rodriguez P, Mallari JP. Kahlon G, et al. Among authors: fejzic h. Bioorg Med Chem Lett. 2021 Jan 15;32:127683. doi: 10.1016/j.bmcl.2020.127683. Epub 2020 Nov 20. Bioorg Med Chem Lett. 2021. PMID: 33227414 Free article.
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease.
Chance JP, Fejzic H, Hernandez O, Istvan ES, Andaya A, Maslov N, Aispuro R, Crisanto T, Nguyen H, Vidal B, Serrano W, Kuwahara B, Pugne Andanado C, Goldberg DE, Mallari JP. Chance JP, et al. Among authors: fejzic h. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1846-1848. doi: 10.1016/j.bmcl.2018.04.010. Epub 2018 Apr 19. Bioorg Med Chem Lett. 2018. PMID: 29691139